The researchers, including those from the German Center for Neurodegenerative Diseases (DZNE), assessed blood samples from a total of 53 men and women with COVID-19 from Berlin and Bonn in Germany, whose course of disease was categorised as mild or severe according to the World Health Organization (WHO) classification.